Arcellx, Inc.a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases announced the appointment of Maryam Abdul-Kareem, J.D., as General Counsel. Ms. Abdul-Kareem brings extensive legal and business expertise in the biopharmaceutical industry, including serving in senior positions at Kinnate Biopharma and AstraZeneca. At Arcellx, she will oversee a broad spectrum of legal, contracts, and compliance matters. 


"Maryam is an exceptional leader and thought partner who brings a broad skill set managing complex legal matters including business development and commercial compliance responsibilities which are valuable as we scale our company through clinical development and towards commercial release," said Rami Elghandour, Arcellx's Chairman and Chief Executive Officer. "In addition to her experience, Maryam is a champion of gender equity and diversity which made her an outstanding fit for the culture we're building at Arcellx. On behalf of our organization and Board of Directors, we welcome Maryam to our team and look forward to benefiting from her leadership and experience as we drive towards delivering our novel technology to patients."


Ms. Abdul-Kareem joins Arcellx from Kinnate Biopharma Inc., where she served as Deputy General Counsel, responsible for legal and corporate compliance matters. Previously, she worked at AstraZeneca Pharmaceuticals LP over a seven-year period in positions of increasing responsibility, most recently as Assistant General Counsel, Corporate, where she led negotiations for numerous complex strategic transactions, including a landmark license deal with the University of Oxford for global rights to the ChAdOx1 COVID-19 vaccine. Prior to AstraZeneca, she served as Associate, Corporate & Securities at Pepper Hamilton LLP (now Troutman Pepper). Ms. Abdul-Kareem began her career as Study Technician/Assistant Toxicologist, Genetic Toxicology at Covance Labs Inc. (now Labcorp); and Clinical Marketing Specialist, Global Marketing at Given Imaging Ltd. (now Medtronic).


Ms. Abdul-Kareem holds a J.D. from Georgetown University Law Center, an M.S. in Biotechnology/Regulatory Affairs from Johns Hopkins University, and a B.S. in Laboratory Animal Science from North Carolina Agricultural and Technical State University. She is an attorney licensed by the Supreme Court of Pennsylvania and the State Bar of California (Registered In-house Counsel).


Source: Arcellx

«« Continuity of Care Between GPs and Patients Improves Patient Outcomes


Omicron Has Half the Risk of Long COVID Compared to Delta »»



Latest Articles

Arcellx,Maryam Abdul-Kareem, General Counsel Arcellx, Inc.a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced the appointment of Maryam Abdul-Kareem, J.D., as General Counsel.